Since the Orphan Drug Act was passed in 1983, pharmaceutical companies have increasingly focused on developing treatments for ...

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice Research conducted ...

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of ...

Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical ...

Approximately 121,000 people are diagnosed with primary advanced or recurrent endometrial cancer each year in Europe ...

The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease ...

At first glance, translating clinical outcome assessments (COAs) from their original language (most commonly English) to ...

The European Medicines Agency’s human medicines committee has recommended Galderma’s nemolizumab to treat atopic dermatitis ...

The results come two months after Merck shared positive results from the phase 3 KEYNOTE-689 trial of Keytruda as a ...

Use language that cuts through the jargon Create more effective, people-centric conversations by connecting lived community ...

The US Food and Drug Administration (FDA) has approved Organon’s Vtama (tapinarof) cream, 1% to treat atopic dermatitis in ...

AbbVie has announced that it will be expanding its immunology pipeline by acquiring Nimble Therapeutics for $200m. The deal ...